前收市價 | 8.20 |
開市 | 無 |
買盤 | 9.70 |
賣出價 | 10.20 |
拍板 | 195.00 |
到期日 | 2026-01-16 |
今日波幅 | 8.20 - 8.20 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 15 |
DaVita's (DVA) strength in its kidney care segment raises optimism about the stock.
Merit Medical's (MMSI) latest asset acquisition is likely to expand its endoscopy portfolio with a minimally-invasive solution for GERD patients, thereby improving patient outcomes.
IceCure Medical's (ICCM) XSense Cryoablation System receives FDA approval, marking a pivotal step in minimally-invasive tumor treatment across multiple medical fields